Literature DB >> 3670379

Merck's new drug free to WHO for river blindness programme.

D Lindley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3670379     DOI： 10.1038/329752a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

Review 1.  The pharmacokinetics and interactions of ivermectin in humans--a mini-review.

Authors:  Aránzazu González Canga; Ana M Sahagún Prieto; M José Diez Liébana; Nélida Fernández Martínez; Matilde Sierra Vega; Juan J García Vieitez
Journal:  AAPS J       Date:  2008-01-25       Impact factor: 4.009

2.  In vitro screening of medicinal plant extracts for macrofilaricidal activity.

Authors:  Mathew Nisha; M Kalyanasundaram; K P Paily; P Vanamail; K Balaraman
Journal:  Parasitol Res       Date:  2006-09-30       Impact factor: 2.289

3.  Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals.

Authors:  Andrew M Bellinger; Mousa Jafari; Tyler M Grant; Shiyi Zhang; Hannah C Slater; Edward A Wenger; Stacy Mo; Young-Ah Lucy Lee; Hormoz Mazdiyasni; Lawrence Kogan; Ross Barman; Cody Cleveland; Lucas Booth; Taylor Bensel; Daniel Minahan; Haley M Hurowitz; Tammy Tai; Johanna Daily; Boris Nikolic; Lowell Wood; Philip A Eckhoff; Robert Langer; Giovanni Traverso
Journal:  Sci Transl Med       Date:  2016-11-16       Impact factor: 17.956

Review 4.  Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance.

Authors:  Roger K Prichard; Timothy G Geary
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-06-15       Impact factor: 4.077

5.  The molecular targets of ivermectin and lotilaner in the human louse Pediculus humanus humanus: New prospects for the treatment of pediculosis.

Authors:  Nicolas Lamassiaude; Berthine Toubate; Cédric Neveu; Pierre Charnet; Catherine Dupuy; Françoise Debierre-Grockiego; Isabelle Dimier-Poisson; Claude L Charvet
Journal:  PLoS Pathog       Date:  2021-02-18       Impact factor: 6.823

Review 6.  Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects.

Authors:  Slobodan P Rendic
Journal:  Arch Toxicol       Date:  2021-03-15       Impact factor: 5.153

7.  Ivermectin Inhibits the Replication of Usutu Virus In Vitro.

Authors:  Maria Elisabeth Wald; Claudia Claus; Andrea Konrath; Hermann Nieper; Aemero Muluneh; Volker Schmidt; Thomas Wilhelm Vahlenkamp; Michael Sieg
Journal:  Viruses       Date:  2022-07-27       Impact factor: 5.818

8.  Filaricidal activities on Onchocerca ochengi and Loa loa, toxicity and phytochemical screening of extracts of Tragia benthami and Piper umbellatum.

Authors:  Fidelis Cho-Ngwa; Elvis Monya; Boris K Azantsa; Faustin Pascal T Manfo; Smith B Babiaka; James A Mbah; Moses Samje
Journal:  BMC Complement Altern Med       Date:  2016-08-30       Impact factor: 3.659

9.  Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa.

Authors:  Adela Ngwewondo; Meng Wang; Faustin Pascal T Manfo; Moses Samje; Jessie N'kam Ganin's; Emmanuel Ndi; Raymond J Andersen; Fidelis Cho-Ngwa
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.